Jazz Pharmaceuticals plc (JAZZ)

Import this data to Google Sheets with:

=jivedata("JAZZ","financials")

Full statements spill as a table. For one cell: =jivedata("JAZZ","Revenue") or =jivedata("JAZZ","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

Jazz Pharmaceuticals plc

JAZZ • CIK 0001232524

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Operating Income (Loss)	$578,580	$716,630	$-430,240	$896,844
Interest Income (Expense), Nonoperating, Net	$-289,438	$-238,097	$-195,051	$-170,982
Foreign Currency Transaction Gain (Loss), before Tax	$8,787	$-8,182	$-2,568	$1,844
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest	$297,929	$470,351	$-627,859	$727,706
Income Tax Expense (Benefit)	$-119,912	$-91,429	$-272,443	$-213,261
Income (Loss) from Equity Method Investments	$-3,009	$-1,660	$-732	$-204
Net Income (Loss) Attributable to Parent	$414,832	$560,120	$-356,148	$940,763
Weighted Average Number of Shares Outstanding, Basic	63,291,000	61,838,000	60,981,000	62,394,000
Weighted Average Number of Shares Outstanding, Diluted	72,066,000	66,007,000	60,981,000	67,694,000
Revenue from Contract with Customer, Excluding Assessed Tax	$3,834,204	$4,068,950	$4,267,586	$4,601,233
Selling, General and Administrative Expense	$1,343,105	$1,385,294	$1,809,271	$1,678,759
Research and Development Expense (Excluding Acquired in Process Cost)	$849,658	$884,000	$782,736	$815,612
Amortization of Intangible Assets	$608,284	$627,313	$654,661	$680,410
Research and Development Asset Acquired Other than Through Business Combination, Written-off	$19,000	$10,000	$947,862	$119,500
Costs and Expenses	$3,255,624	$3,352,320	$4,697,826	$3,704,389

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$1,506,310	$2,412,864	$1,391,899	$1,619,800
Investments	$120,000	$580,000	$1,050,000	$580,000
Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization	$169,646	$173,413	$199,857	$212,000
Accounts Receivable, after Allowance for Credit Loss, Current	$705,794	$716,765	$830,747	$880,900
Operating Lease, Right-of-Use Asset	$65,340	$53,582	$58,880	$52,100
Inventory, Net	$597,039	$480,445	$416,962	$443,000
Intangible Assets, Net (Excluding Goodwill)	$5,418,039	$4,755,695	$4,429,510	$4,029,500
Prepaid Expense, Current	$185,476	$177,411	$152,481	$200,000
Goodwill	$1,753,130	$1,716,323	$1,829,340	$1,799,800
Other Assets, Current	$320,809	$261,543	$323,954	$244,500
Deferred Income Tax Assets, Net	$477,834	$560,245	$869,130	$926,400
Assets, Current	$3,435,428	$4,629,028	$4,166,043	$3,968,200
Debt Issuance Costs, Noncurrent, Net	$6,478	$9,489	$7,550	$6,600
Other Assets, Noncurrent	$67,464	$114,482	$99,030	$86,300
Assets	$11,393,359	$12,012,257	$11,659,340	$11,080,900
Long-term Debt, Excluding Current Maturities	$5,107,988	$6,077,640	$4,328,354	$3,335,000
Operating Lease, Liability, Noncurrent	$59,225	$38,938	$50,892	$43,600
Deferred Income Tax Liabilities, Net	$847,706	$676,736	$594,470	$528,900
Other Liabilities, Noncurrent	$104,751	$86,614	$124,519	$140,900
Accounts Payable, Current	$102,750	$77,869	$122,061	$128,500
Accrued Liabilities, Current	$793,914	$910,947	$1,034,170	$1,030,000
Long-term Debt, Current Maturities	$604,954	$31,000	$1,029,903	$1,016,400
Taxes Payable, Current	$35,074	$18,757	$56,387	$55,900
Liabilities, Current	$1,536,692	$1,038,573	$2,242,521	$2,230,800
Common Stock, Value, Issued	$6	$6	$6	$0
Additional Paid in Capital, Common Stock	$3,699,954	$3,913,542	$4,240,472	$4,331,600
Accumulated Other Comprehensive Income (Loss), Net of Tax	$-842,147	$-947,667	$-568,598	$-662,500
Retained Earnings (Accumulated Deficit)	$878,656	$1,127,347	$646,176	$1,132,000
Stockholders' Equity Attributable to Parent	$3,736,997	$4,093,756	$4,318,584	$4,801,700
Accounts Receivable, Allowance for Credit Loss, Current	$21,136	$32,691	$17,294	$17,294
Common Stock, Shares Authorized	300,000,000	300,000,000	300,000,000	300,000,000
Common Stock, Shares, Issued	62,255,000	60,631,000	61,435,000	61,435,000
Finance Lease, Right-of-Use Asset, after Accumulated Amortization	$4,450	$3,917	$2,804	$2,804
Operating Lease, Liability, Current	$19,019	$14,331	$14,278	$14,278
Finance Lease, Liability, Current	$428	$448	$439	$439
Finance Lease, Liability, Noncurrent	$5,039	$4,561	$3,440	$3,440

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss) Attributable to Parent	$414,832	$560,120	$-356,148	$940,763
Net Cash Provided by (Used in) Operating Activities	$1,092,007	$1,395,908	$1,355,773	$1,661,034
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$1,137	$-1,675	$6,555	$-764
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$624,828	$906,554	$-1,020,965	$429,919
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$1,506,310	$2,412,864	$1,391,899	$1,374,253
Research and Development Asset Acquired Other than Through Business Combination, Written-off	$19,000	$10,000	$947,862	$119,500
Payments to Acquire Investments	$390,100	$1,305,125	$1,830,275	$1,920,225
Amortization of Intangible Assets	$608,284	$627,313	$654,661	$680,410
Payments to Acquire Assets, Investing Activities	—	—	$858,053	$0
Share-based Payment Arrangement, Noncash Expense	$226,841	$248,045	$291,133	$306,779
Payments to Acquire Intangible Assets	$0	$0	$108,500	$83,500
Payments to Acquire Property, Plant, and Equipment	$23,962	$38,070	$58,752	$69,704
Depreciation	$30,412	$32,754	$41,636	$37,505
Proceeds from Sale of Other Productive Assets	—	—	$28,167	$228,167
Proceeds from Sale, Maturity and Collection of Investments	$270,000	$845,000	$1,360,000	$1,820,000
Deferred Income Tax Expense (Benefit)	$-260,217	$-208,327	$-444,971	$-439,619
Net Cash Provided by (Used in) Investing Activities	$-163,062	$-508,195	$-1,509,913	$-221,962
Tangible Asset Impairment Charges	$61,014	$0	$0	$0
Other Noncash Income (Expense)	$-11,343	$-17,978	$-3,103	$2,439
Repayments of Secured Debt	$31,000	$31,000	$781,000	$31,000
Payments for Repurchase of Common Stock	$269,761	$311,429	$125,023	$0
Payment, Tax Withholding, Share-based Payment Arrangement	$50,952	$57,753	$75,220	$118,908
Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised	$46,459	$20,647	$107,863	$141,519
Repayments of Convertible Debt	$0	$575,000	$0	$1,000,000
Payments of Debt Restructuring Costs	—	$5,716	$0	$0
Proceeds from Convertible Debt	—	$980,767	$0	$0
Net Cash Provided by (Used in) Financing Activities	$-305,254	$20,516	$-873,380	$-1,008,389
Interest Paid, Excluding Capitalized Interest, Operating Activities	$333,112	$314,822	$248,553	$248,553
Income Taxes Paid, Net	—	—	$121,808	$121,808
Increase (Decrease) in Accounts Receivable	$51,883	$21,115	$106,279	$168,209
Increase (Decrease) in Inventories	$13,420	$45,542	$86,041	$131,889
Increase (Decrease) in Prepaid Expense and Other Assets	$126,179	$-10,574	$-29,030	$-77,618
Increase (Decrease) in Accounts Payable	$9,603	$-20,073	$39,851	$40,486
Increase (Decrease) in Accrued Liabilities	$-23,245	$86,159	$77,096	$153,047
Increase (Decrease) in Income Taxes Payable	$25,220	$-14,742	$37,224	$-22,346
Increase (Decrease) in Other Operating Liabilities	—	—	$28,018	$14,518

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("JAZZ","financials")

Full statements spill as a table. For one cell: =jivedata("JAZZ","Revenue") or =jivedata("JAZZ","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.